Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Beltrame

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Cell Death & Disease|July 15, 2022
Tumor treating fields affect mesothelioma cell proliferation by exerting histotype-dependent cell cycle checkpoint activations and transcriptional modulationsLaura Mannarino, Federica Mirimao, Nicolò Panini, et al.
Immunity|February 14, 2012
Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansionVeronica Santarlasci, Laura Maggi, Manuela Capone, et al.
Biomed Research International|August 22, 2014
Analysis of differential miRNA expression in primary tumor and stroma of colorectal cancer patientsGiuseppina Della Vittoria Scarpati, Enrica Calura, Mariacristina Di Marino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2020
Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian CancerLara Paracchini, Luca Beltrame, Tommaso Grassi, et al.
Oncotarget|December 10, 2016
The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimusRamiro Vázquez, María E Riveiro, Lucile Astorgues-Xerri, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2017
Breast and renal cancer-Derived endothelial colony forming cells share a common gene signatureFrancesco Moccia, Vittoria Fotia, Richard Tancredi, et al.
Neurobiology of Disease|December 13, 2016
Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsyValentina Iori, Anand M Iyer, Teresa Ravizza, et al.
The Lancet. Oncology|February 25, 2011
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collectionsSergio Marchini, Duccio Cavalieri, Robert Fruscio, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2012
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancerSergio Marchini, Robert Fruscio, Luca Clivio, et al.
JAMA Network Open|July 2, 2020
Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer DiagnosisLara Paracchini, Chiara Pesenti, Martina Delle Marchette, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Cell Death & Disease|July 15, 2022
Tumor treating fields affect mesothelioma cell proliferation by exerting histotype-dependent cell cycle checkpoint activations and transcriptional modulationsLaura Mannarino, Federica Mirimao, Nicolò Panini, et al.
Immunity|February 14, 2012
Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansionVeronica Santarlasci, Laura Maggi, Manuela Capone, et al.
Biomed Research International|August 22, 2014
Analysis of differential miRNA expression in primary tumor and stroma of colorectal cancer patientsGiuseppina Della Vittoria Scarpati, Enrica Calura, Mariacristina Di Marino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2020
Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian CancerLara Paracchini, Luca Beltrame, Tommaso Grassi, et al.
Oncotarget|December 10, 2016
The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimusRamiro Vázquez, María E Riveiro, Lucile Astorgues-Xerri, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2017
Breast and renal cancer-Derived endothelial colony forming cells share a common gene signatureFrancesco Moccia, Vittoria Fotia, Richard Tancredi, et al.
Neurobiology of Disease|December 13, 2016
Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsyValentina Iori, Anand M Iyer, Teresa Ravizza, et al.
The Lancet. Oncology|February 25, 2011
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collectionsSergio Marchini, Duccio Cavalieri, Robert Fruscio, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2012
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancerSergio Marchini, Robert Fruscio, Luca Clivio, et al.
JAMA Network Open|July 2, 2020
Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer DiagnosisLara Paracchini, Chiara Pesenti, Martina Delle Marchette, et al.
Pageof 6